TY  - RPRT
TI  - Overcoming Immunological Barriers in MSC-Derived Insulin-Producing Cells through CRISPR-Based Hypoimmunogenic Engineering and Translational Perspectives for Type 1 Diabetes.
AU  - Zahid Yaseen
AU  - Mothilal M
PY  - 2026
DO  - 10.1007/s12015-026-11184-8
UR  - https://pubmed.ncbi.nlm.nih.gov/42387220/
ID  - 42387220
ER  -